GGrantIndex
Sort

78,016 grants matching breast cancer

RANK Ligand Inhibition - a Potential Chemoprevention Strategy for Women at High Genetic Risk of Breast Cancer HHSN2612015000181 TO: HHSN26100009 PP: 9/17/18 to 3/16/2021

$643,386
Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2018 · CA

Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer

$643,370
Jessica Ezzell Hunter · Kaiser Foundation Research Institute · U01 · FY2021 · CA

Bioengineering adipocytes for cancer therapy

$643,369
Nadav Ahituv · University Of California, San Francisco · R01 · FY2025 · CA

Every Day Counts: A lifestyle program for women metastatic breast cancer

$643,291
Melinda R Stolley · Medical College Of Wisconsin · R01 · FY2025 · CA

Biochemistry of Pre-mRNA Splicing

$643,281
Adrian R Krainer · Cold Spring Harbor Laboratory · R01 · FY2008 · GM

Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care

$643,259
Shawna V. Hudson · Rbhs-Robert Wood Johnson Medical School · R01 · FY2016 · CA

Bioengineering adipocytes for cancer therapy

$643,221
Nadav Ahituv · University Of California, San Francisco · R01 · FY2024 · CA

Health Consequences of Fear of Cancer Recurrence in Breast Cancer Survivors and Partners

$643,177
Jean-Philippe Laurenceau · University Of Delaware · R01 · FY2025 · CA

Statistical Methods in Disease Risk Assessment and Prediction

$643,109
Shanshan Zhao · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES

Sleep Disturbance, Inflammation, and Cellular Aging in Breast Cancer Survivors

$643,101
Michael R Irwin · University Of California Los Angeles · R01 · FY2018 · CA

Secondary Prevention through Surveillance and Intervention

$643,007
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2020 · CA

NOTCH3 SIGNALING POTENTIATES OSTEOLYTIC BONE METASTASIS OF BREAST CANCER

$643,000
Children'S Hospital Corporation, The · · FY2009 · Department of the Army

Fit2ThriveMIND: Optimizing a mHealth Physical Activity Intervention with Mindful Awareness Lessons in Breast Cancer Survivors

$642,979
Siobhan Marie Phillips · Northwestern University At Chicago · R01 · FY2023 · CA

Risk prediction methods

$642,941
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Design and characterization of bacterial population dynamics in solid tumor models

$642,937
Jeff M Hasty · University Of California, San Diego · R01 · FY2021 · EB

The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis

$642,928
William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA

Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment

$642,911
Hossein Khiabanian · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA

Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment

$642,911
Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA

Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment

$642,911
Hossein Khiabanian · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA

Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment

$642,910
Hossein Khiabanian · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA

LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU

$642,897
Yale University · R01 · FY2004 · CA

Mechanisms Regulating Neurotensin Secretion and Function

$642,896
Bernard Mark Evers · University Of Kentucky · R01 · FY2024 · DK

Proteolytic disregulation of the S326C mutant OGG1 DNA repair enzyme

$642,889
Michele K Evans · National Institute On Aging · ZIA · FY2013 · AG

DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment

$642,880
Mary Beth Terry · Columbia University Health Sciences · U01 · FY2018 · ES

Integrating Epigenetic Modulation into DNA Damage Repair

$642,872
Pamela N Munster · University Of California, San Francisco · R01 · FY2023 · CA